APLASTIC ANEMIA
Clinical trials for APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for cancer survivors with treatment-resistant anemia
Disease control Not yet recruitingThis study tests a drug called romiplostim N01 in 43 adults with severe anemia that did not improve with standard treatments. The anemia was caused by chemotherapy or radiation therapy for cancer. The goal is to see if the drug can safely increase blood cell counts and reduce the…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
Cord blood cells aim to break transfusion dependence in aplastic anemia
Disease control Not yet recruitingThis study tests a new treatment called CK0801 for adults with aplastic anemia who still need blood transfusions after standard treatments. CK0801 uses immune cells from donated cord blood to help the body make its own blood cells again. The goal is to see if it is safe and can r…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New hope for cancer survivors with rare bone marrow failure?
Disease control Not yet recruitingThis study tests a drug called romiplostim N01 in 43 adults whose severe anemia did not improve after standard treatments. The anemia was caused by chemotherapy or radiation for cancer. The goal is to see if the drug can help the bone marrow make more blood cells and improve symp…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New hope for kids with severe aplastic anemia: drug combo aims to restore blood cells
Disease control Not yet recruitingThis study tests whether adding romiplostim to standard immunosuppressive therapy helps children and young adults with severe aplastic anemia recover their own blood cell production. The trial includes both newly diagnosed patients and those whose disease has returned or not resp…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Anjali Sharathkumar • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New hope for rare blood disorder: daratumumab trial targets refractory aplastic anemia
Disease control Not yet recruitingThis study tests a drug called daratumumab in people with aplastic anemia that hasn't improved with standard treatments. The goal is to see if it is safe and can help the body make more blood cells. About 37 participants will receive multiple doses, and researchers will check for…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC